A detailed history of Hurley Capital, LLC transactions in Rebus Holdings, Inc. stock. As of the latest transaction made, Hurley Capital, LLC holds 64 shares of RBSH stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$0.0 - $0.0 $0 - $0
64 New
64 $0

Others Institutions Holding RBSH

# of Institutions
2
Shares Held
66
Call Options Held
0
Put Options Held
0

About Rebus Holdings, Inc.


  • Ticker RBSH
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,900
  • Description
  • Rebus Holdings, Inc. focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. The company was founded in 2003 and is based in Westlake Village, California.
More about RBSH
Track This Portfolio

Track Hurley Capital, LLC Portfolio

Follow Hurley Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurley Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hurley Capital, LLC with notifications on news.